A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis

被引：4
|
作者：
Yamazaki, Haruhiko [1 ]
Iwasaki, Hiroyuki [1 ]
Yamashita, Toshinari [1 ]
Yoshida, Tatsuya [1 ]
Suganuma, Nobuyasu [1 ]
Yamanaka, Takashi [1 ]
Masudo, Katsuhiko [2 ]
Nakayama, Hirotaka [3 ]
Kohagura, Kaori [3 ]
Rino, Yasushi [3 ]
Masuda, Munetaka [3 ]
机构：
[1] Kanagawa Canc Ctr, Dept Breast & Endocrine Surg, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Med Ctr, Dept Breast andThyroid Surg, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Sch Med, Dept Surg, Yokohama, Kanagawa, Japan
来源：
CASE REPORTS IN ENDOCRINOLOGY | 2018年 / 2018卷
关键词：
D O I：
10.1155/2018/7875929
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 63-year-old man was diagnosed with multiple lung metastases from anaplastic thyroid cancer and received lenvatinib. Followup computed tomography on day 34 of lenvatinib treatment showed pneumothorax. The pneumothorax was temporarily improved with chest drainage. However, pleurodesis was performed to treat a relapse of the pneumothorax. Pneumothorax during chemotherapy for a malignant tumor is considered a relatively rare complication. This case is the first documentation that pneumothorax may develop during lenvatinib treatment. The possible development of pneumothorax should be considered when lenvatinib is used in patients with lung metastasis.
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
    Yamazaki, Haruhiko
    Iwasaki, Hiroyuki
    Suganuma, Nobuyasu
    Toda, Soji
    Masudo, Katsuhiko
    Nakayama, Hirotaka
    Rino, Yasushi
    Masuda, Munetaka
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2019,
  • [12] Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report
    Luongo, Cristina
    Porcelli, Tommaso
    Sessa, Francesca
    De Stefano, Maria Angela
    Scavuzzo, Francesco
    Damiano, Vincenzo
    Klain, Michele
    Bellevicine, Claudio
    Matano, Elide
    Troncone, Giancarlo
    Schlumberger, Martin
    Salvatore, Domenico
    CURRENT ONCOLOGY, 2021, 28 (06) : 5401 - 5407
  • [13] Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
    Iwasaki, Hiroyuki
    Toda, Soji
    Takahashi, Akari
    Masudo, Katsuhiko
    ONCOLOGY LETTERS, 2023, 26 (03)
  • [14] Prognostic significance of lung metastasis-related finding in lenvatinib treatment for differentiated thyroid cancer
    Haruhiko Yamazaki
    Hiroyuki Iwasaki
    Katsuhiko Masudo
    Soji Toda
    Ai Matsui
    Yasushi Rino
    Endocrine, 2022, 78 : 543 - 551
  • [15] Prognostic significance of lung metastasis-related finding in lenvatinib treatment for differentiated thyroid cancer
    Yamazaki, Haruhiko
    Iwasaki, Hiroyuki
    Masudo, Katsuhiko
    Toda, Soji
    Matsui, Ai
    Rino, Yasushi
    ENDOCRINE, 2022, 78 (03) : 543 - 551
  • [16] Common carotid artery rupture during treatment with lenvatinib for anaplastic thyroid cancer
    Kazufumi Obata
    Iwao Sugitani
    Aya Ebina
    Yoshiya Sugiura
    Kazuhisa Toda
    Shunji Takahashi
    Kazuyoshi Kawabata
    International Cancer Conference Journal, 2016, 5 (4) : 197 - 201
  • [17] Common carotid artery rupture during treatment with lenvatinib for anaplastic thyroid cancer
    Obata, Kazufumi
    Sugitani, Iwao
    Ebina, Aya
    Sugiura, Yoshiya
    Toda, Kazuhisa
    Takahashi, Shunji
    Kawabata, Kazuyoshi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2016, 5 (04): : 197 - 201
  • [18] Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer
    Iniguez-Ariza, Nicole M.
    Ryder, Mabel M.
    Hilger, Crystal R.
    Bible, Keith C.
    THYROID, 2017, 27 (07) : 923 - 927
  • [19] Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer
    Li, Xiu Juan
    Gangadaran, Prakash
    Kalimuthu, Senthilkumar
    Oh, Ji Min
    Zhu, Liya
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    Ahn, Byeong-Cheol
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (11) : 2583 - 2592
  • [20] Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
    Su, Xi
    Liu, Jiaxin
    Zhang, Haihong
    Gu, Qingqing
    Zhou, Xinrui
    Ji, Meiju
    Yao, Demao
    ONCOTARGETS AND THERAPY, 2020, 13 : 11183 - 11192
12345